Author

S. Sebens

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Traulsen· 1 shared C. Roecken· 1 shared D. Guergen· 1 shared J. Hoffmann· 1 shared L.-M. Philipp· 1 shared M. Becker· 1 shared M. Raatz· 1 shared S. Giaimo· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Traulsen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Understanding and leveraging phenotypic plasticity during metastasis formation

S. Shah, L.-M. Philipp, S. Giaimo, S. Sebens, A. Traulsen, M. Raatz

This study develops a mathematical model to understand how phenotypic plasticity influences metastasis formation and shows it can protect tumors from treatment, suggesting it as a therapeutic target.

bioRxiv · Nov 7, 2022Cancer Biology

Breaking the Crosstalk of the Cellular Tumorigenic Network in NSCLC by a Highly Effective Drug Combination

D. Guergen, T. Conrad, M. Becker, S. Sebens, C. Roecken, J. Hoffmann, S. Langhammer

This study shows a low-dose drug combination effectively suppresses NSCLC PDX tumors with high response and complete remission rates.

bioRxiv · Oct 23, 2021 · PreprintCancer Biology